MedMen Enterprises Inc.
MMNFF · OTC
6/25/2022 | 6/26/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $140,812 | $145,066 | $157,112 | $129,963 |
| % Growth | -2.9% | -7.7% | 20.9% | – |
| Cost of Goods Sold | $71,084 | $77,777 | $98,991 | $69,086 |
| Gross Profit | $69,727 | $67,289 | $58,121 | $60,878 |
| % Margin | 49.5% | 46.4% | 37% | 46.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $108,725 | $124,586 | $200,274 | $234,650 |
| SG&A Expenses | $111,930 | $125,695 | $210,916 | $262,199 |
| Sales & Mktg Exp. | $3,206 | $1,109 | $10,642 | $27,549 |
| Other Operating Expenses | $19,099 | $30,894 | $39,954 | $20,975 |
| Operating Expenses | $131,029 | $156,590 | $250,870 | $283,174 |
| Operating Income | -$61,302 | -$89,300 | -$192,749 | -$222,296 |
| % Margin | -43.5% | -61.6% | -122.7% | -171% |
| Other Income/Exp. Net | -$114,149 | -$67,403 | -$328,917 | -$22,300 |
| Pre-Tax Income | -$175,451 | -$143,611 | -$515,348 | -$263,232 |
| Tax Expense | -$9,896 | $1,834 | -$39,599 | $13,815 |
| Net Income | -$165,555 | -$145,445 | -$475,749 | -$277,047 |
| % Margin | -117.6% | -100.3% | -302.8% | -213.2% |
| EPS | -0.14 | -0.27 | -1.76 | -2.62 |
| % Growth | 48.1% | 84.7% | 32.8% | – |
| EPS Diluted | -0.14 | -0.27 | -1.76 | -2.62 |
| Weighted Avg Shares Out | 1,153,538 | 530,980 | 270,419 | 105,915 |
| Weighted Avg Shares Out Dil | 1,153,538 | 530,980 | 270,419 | 105,915 |
| Supplemental Information | – | – | – | – |
| Interest Income | $92 | $649 | $766 | $702 |
| Interest Expense | $43,073 | $61,370 | $49,487 | $22,817 |
| Depreciation & Amortization | $25,739 | $34,458 | $43,709 | $23,544 |
| EBITDA | -$63,658 | -$54,843 | -$149,039 | -$198,752 |
| % Margin | -45.2% | -37.8% | -94.9% | -152.9% |